Gráfico del Precio de Acciones IKT
IKT Ganando
Inhibikase Therapeutics Inc
$1.84
-2.38%
$-0.04
Hasta hoy:Apr 28, 11:42:25 GMT-4
Atrás
Inhibikase Therapeutics Inc (IKT) Ganando
Estadísticas clave
Cierre Anterior
$1.89
Precio de apertura
$1.89
Rango del día
$1.84 - $1.89
Rango de 52 semanas
$1.33 - $2.36
Volumen
188.4K
Volumen promedio
1.5M
Rendimiento de dividendos
--
EPS (TTM)
-1.15
Cap. de mercado
$243.5M
¿Qué es IKT?
Inhibikase Therapeutics, Inc. is a clinical-stage pharmaceutical company, which engages in development of protein kinase inhibitor therapeutics to modify the course of Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. The company is headquartered in Wilmington, Delaware and currently employs 15 full-time employees. The company went IPO on 2020-12-23. The firm is focused on developing Abelson Tyrosine Kinase inhibitor therapeutics for cardiopulmonary disease. The Company’s multi-therapeutic pipeline includes IKT-001, a prodrug of imatinib mesylate, for pulmonary arterial hypertension (PAH).
Características
Recursos
© 2026 Finture Development Limited. Todos los derechos reservados.